Clinical Trials Logo
  1. Home
  2. Cardiovascular Risk
  3. NCT04506749

To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects — JC  

Cardiovascular Risk Clinical Trial

Official title:
Clinical Trial to Evaluate the Efficacy of a Nutraceutical Versus Placebo in Reducing Cardiovascular Risk in Healthy Subjects

Clinical Trial Summary

Single-blind, double-blind, controlled, randomized clinical trial of two parallel branches depending on the product consumed (experimental product and placebo product) and single-center with the objective of evaluating the effect of the investigational product on cardiovascular risk reduction.

Clinical Trial Description

Subjects who meet the selection criteria will make a total of two visits to the research laboratory and will carry out the tests established in the protocol. Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain results. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04506749
Study type Interventional
Source Universidad Católica San Antonio de Murcia
Contact
Status Completed
Phase N/A
Start date November 11, 2019
Completion date September 18, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT01139827 - Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography N/A
Recruiting NCT05767073 - LIVES: Personalized Lifestyle Intervention for Patients With Depression N/A
Completed NCT04626505 - Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. Phase 2
Completed NCT00856882 - The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors N/A
Completed NCT04330937 - Clinical Trial on the Effectiveness of Citrolive N/A
Completed NCT01781416 - Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk N/A
Completed NCT01475513 - Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women Phase 4
Enrolling by invitation NCT06122961 - Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed NCT03412175 - CREATION Health Lifestyle Intervention N/A
Completed NCT02144922 - Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients Phase 4
Completed NCT00921752 - C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS) N/A
Completed NCT00697580 - Strength and Nutrition Outcomes for Latino Adolescents N/A
Enrolling by invitation NCT04450914 - Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP) N/A
Completed NCT01003574 - Evaluation of Cardiovascular Health Outcomes Among Survivors N/A
Not yet recruiting NCT06118281 - ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Phase 3
Completed NCT01441323 - Strength Training and Nutrition Development for African American Youth N/A
Completed NCT01103648 - Effect of Simvastatin and Ezetimibe on Lipid and Inflammation N/A
Completed NCT01015092 - Cardiovascular Risk Evaluation and Antiretrovirals in HIV N/A
Not yet recruiting NCT05882266 - The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals With Cardiovascular(CVD) Risk N/A
Completed NCT00988754 - School Based Health Promotion Program in Secondary Schools N/A